AZAINDAZOLE COMPOUNDS AS CCR1 RECEPTOR ANTAGONISTS
Disclosed are compounds of the formula (I), useful for treating a variety of diseases and disorders that are mediated or sustained through the activity of CCR1 including autoimmune diseases, such as rheumatoid arthritis and multiple sclerosis. Also disclosed are methods of making and methods of using same.
-
Page/Page column 189
(2010/04/27)
Enzymatic resolution of (R)- and (S)-2-(1-hydroxyalkyl)thiazoles, synthetic equivalents of (R)- and (S)-2-hydroxy aldehydes
-
Allevi, Pietro,Ciuffreda, Pierangela,Tarocco, Giorgio,Anastasia, Mario
p. 4144 - 4147
(2007/10/03)
More Articles about upstream products of 89464-29-9